Metabolomic analysis of the Puerarin hypoglycemic activity via AMPK-mTOR and PPARγ-NF-κB signaling pathways
- 2 April 2024
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 130, 155546
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective reviewMolecular and Cellular Biochemistry, 2022
- Transcriptomic and Metabonomic Profiling Reveals the Antihyperlipidemic Effects of Tartary Buckwheat Sprouts in High-Fat-Diet-Fed MiceJournal of Agricultural and Food Chemistry, 2022
- Extracellular vesicles in β cell biology: Role of lipids in vesicle biogenesis, cargo, and intercellular signalingMolecular Metabolism, 2022
- Puerarin improves hepatic glucose and lipid homeostasis in vitro and in vivo by regulating the AMPK pathwayFood & Function, 2021
- Genetics of diabetes mellitus and diabetes complicationsNature Reviews Nephrology, 2020
- Ginsenoside Rg1 and the control of inflammation implications for the therapy of type 2 diabetes: A review of scientific findings and call for further researchPharmacological Research, 2020
- The heterogeneous pathogenesis of type 1 diabetes mellitusNature Reviews Endocrinology, 2019
- Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitusNature Reviews Endocrinology, 2019
- Melatonin in type 2 diabetes mellitus and obesityNature Reviews Endocrinology, 2018
- Roles of mTOR complexes in the kidney: implications for renal disease and transplantationNature Reviews Nephrology, 2016